Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Erytech Pharma SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jul 2015 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Erytech Pharma SA

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

09 Jul 2015 Wright Reports 55 $75.00

Erytech Pharma SA (ERYP) - Financial Analysis Review

Erytech Pharma SA (ERYP) - Financial Analysis Review Summary Erytech Pharma SA (Erytech Pharma) is a bio-pharmaceutical...

08 Jun 2015 GlobalData 42 $125.00

Company Snapshot - Erytech Pharma

A director at Erytech Pharma sold 2,000 shares at 34.634EUR and the significance rating of the trade was 51/100. Is that inf...

08 Jun 2015 Directors Deals Ltd. 1 $12.00

ERYTECH PHARMA: ADR - GRASPA SAFETY REINFORCED BY EAP

A recent update from the Graspa Expanded Access Program (EAP) in France reaffirms its impressive safety profile, with patien...

27 May 2015 Edison Investment Research 5 $10.00

ERYTECH PHARMA - GRASPA SAFETY REINFORCED BY EAP

A recent update from the Graspa Expanded Access Program (EAP) in France reaffirms its impressive safety profile, with patien...

27 May 2015 Edison Investment Research 5 $10.00

Erytech Pharma SA (ERYP) - Financial Analysis Review

Erytech Pharma SA (ERYP) - Financial Analysis Review Summary Erytech Pharma SA (Erytech Pharma) is a bio-pharmaceutical...

12 Feb 2015 GlobalData 38 $125.00

ERYTECH PHARMA - DEUTSCHES EIGENKAPITALFORUM

Graspa has successfully completed a Phase III trial in acute lymphoblastic leukaemia (ALL), which should pave the way for fir...

28 Jan 2015 Edison Investment Research 2 $10.00

ERYTECH PHARMA - MORE DETAILED GRASPA DATA REINFORCE ITS POTENTIAL

Additional details on Erytech’s Graspa Phase III acute lymphoblastic leukaemia (ALL) trial have been disclosed in conjunction...

06 Jan 2015 Edison Investment Research 7 $10.00

Erytech Pharma SA (ERYP) - Financial Analysis Review

Erytech Pharma SA (ERYP) - Financial Analysis Review Summary Erytech Pharma SA (Erytech Pharma) is a bio-pharmaceutical...

10 Dec 2014 GlobalData 40 $125.00